General · 9 June 2026

GSK's $10.6B purchase pulls FTSE 100 down

Investors saw London’s main share index slip as GSK shares fell after announcing a major purchase. On Tuesday, the drugmaker said it plans to buy U.S. cancer drug developer Nuvalent for $10.6 billion, while the FTSE 100 dropped 0.3% and the FTSE 250 added 0.2%. By 0810 GMT, the benchmark stood at 10,341 points and GSK stock was down 2.8%.

By BriefTea Editorial · 9 June 2026 at 12:55

Reported by Reuters · How we write briefs

Get the app

More briefs

PoliticsBurnham to end indefinite jail terms by parliament's end WorldArizona desert deaths of 19 migrants last month hit a two-year record SportsCollege football player MicahJo Barnett dies after sideline emergency WorldFar-right party wins first lower-house seat in Western Australia GeneralMet Office forecasts more heavy showers across 107 areas Monday WorldMasked Israeli settlers attacked homes in West Bank's Qusra on Saturday More top stories → Browse all stories →